We are part of the problem
- PMID: 18577659
We are part of the problem
Comment on
-
Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness.Br J Ophthalmol. 2007 Sep;91(9):1244-6. doi: 10.1136/bjo.2007.116616. Epub 2007 Apr 12. Br J Ophthalmol. 2007. PMID: 17431015 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources